A carregar...
Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study
AIMS: Dipeptidyl-peptidase-4 inhibitors (DPP-4i) have been implicated with an increased pancreatic cancer risk. We therefore compared pancreatic cancer incidence and diagnostic work-up among initiators of DPP-4i versus sulfonylureas (SU) and thiazolidinediones (TZD). METHODS: Medicare claims data we...
Na minha lista:
Publicado no: | Diabetes Obes Metab |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4227935/ https://ncbi.nlm.nih.gov/pubmed/25109825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12379 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|